XIAP deficiency and MEFV variants resulting in an autoinflammatory lymphoproliferative syndrome.
A 16-year-old boy of Caucasian ethnicity was evaluated for recurrent febrile episodes occurring during most of his life without establishment of any microbial aetiology. During febrile episodes he developed extensive splenomegaly, lymphadenopathy, anaemia, severe abdominal pain and general malaise. Lymph node biopsies demonstrated inflammation and sinus histiocytosis but no malignancy or granuloma. The patient underwent seroconversion for Epstein-Barr virus (EBV) infection during the hospitalisation. Genetic testing identified a hemizygous frameshift mutation in the X linked inhibitor of apoptosis (XIAP)-gene as well as variants in the MEFV gene indicating Familial Mediterranean Fever (FMF). XIAP expression was markedly reduced in the patient, while a functional assay assessing tumour necrosis factor (TNF)α production of monocytes in response to NOD2 stimulation displayed reduced activity. We suggest that the heterozygous MEFV variants and the hemizygous XIAP variant in combination triggered the prolonged and pathological inflammatory response to EBV infection.
Department of Clinical Immunology, Aarhus University Hospital, Aarhus N, Denmark.
Mette
M
Christiansen
Universitatsklinikum Freiburg Medizinische Universitatsklinik, Freiburg im Breisgau, Baden-Württemberg, Germany.
Sandra
S
Ammann
Universitatsklinikum Freiburg Medizinische Universitatsklinik, Freiburg im Breisgau, Baden-Württemberg, Germany.
Carsten
C
Speckmann
Aarhus University Hospital, Aarhus N, Denmark.
Trine Hyrup
TH
Mogensen
Blood. 2010 Dec 23;116(26):5824-31
20855862
Trends Immunol. 2012 Nov;33(11):535-45
22836014
Clin Immunol. 2013 Oct;149(1):133-41
23973892
J Rheumatol. 2006 Jun;33(6):1089-92
16755655
Arthritis Rheum. 2009 Jun;60(6):1851-61
19479870
Genet Med. 2011 Jun;13(6):487-98
21358337
Orphanet J Rare Dis. 2015 Mar 25;10:34
25887307
Blood. 2011 Feb 3;117(5):1522-9
21119115
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14524-9
19667203
Discov Med. 2011 Mar;11(58):221-31
21447281
EMBO Mol Med. 2013 Aug;5(8):1278-95
23818254
Blood. 2010 Nov 4;116(18):3398-408
20660790
Clin Exp Immunol. 2014 Jun;176(3):394-400
24611904
Arthritis Rheum. 2009 Nov;60(11):3476-84
19877056
Nature. 2006 Nov 2;444(7115):110-4
17080092
Blood. 2013 Feb 7;121(6):877-83
23131490
Immunity. 2009 Jun 19;30(6):789-801
19464198
Pediatr Blood Cancer. 2016 Feb;63(2):355-7
26398727
Front Microbiol. 2016 Mar 31;7:456
27066000
Mol Cell. 2012 Jun 29;46(6):746-58
22607974
Trends Immunol. 2004 Jun;25(6):280-8
15145317
PLoS Pathog. 2008 Aug 29;4(8):e1000142
18769721
Arthritis Rheum. 2009 Jun;60(6):1862-6
19479871